Inhibitory regulation of osteoclast differentiation by interleukin-3 via regulation of c-Fos and Id protein expression

Journal of Cellular Physiology

Volumn 227, Issue 5, 2012, Pages 1851-1860

  Oh, Jaemin ^a   Lee, Myeung Su ^a   Yeon, Jeong Tae ^a   Choi, Sik Won ^a   Kim, Hun Soo ^a   Shim, Hyeok ^a   Lee, Sam Youn ^a   Youn, Byung Soo ^b   Yokota, Yoshifumi ^c   Kim, Jung Ha ^d   Kwak, Han Bok ^a  

^a Wonkwang University   (South Korea)

^b AdipoGen   (South Korea)

^c UNIVERSITY OF FUKUI   (Japan)

^d Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION PROTEIN; INTERLEUKIN 3; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; TRANSCRIPTION FACTOR NFAT;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE EROSION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM;

ADULT; AGED; ANIMALS; BONE AND BONES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; INHIBITOR OF DIFFERENTIATION PROTEIN 2; INTERLEUKIN-3; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MALE; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MIDDLE AGED; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FOS; RANDOM ALLOCATION; RANK LIGAND;

EID: 84862937445     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22913     Document Type: Article

References (34)

1. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T. 1999. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J Exp Med 190: 1741-1754.
2. Barreda DR, Hanington PC, Belosevic M. 2004. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 28: 509-554.
3. Benezra R, Davia RL, Lockshon D, Turner DL, Weintraub H. 1990. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61: 49-59.
4. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
5. Chan AS, Jensen KK, Skokos D, Doty S, Lederman HK, Kaplan RN, Rafii S, Rivella S, Lyden D. 2009. Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis. PLoS ONE 4: e7955.
6. Chaudhary J, Skinner MK. 1999. Basic helix-loop-helix proteins can act at the E-box within the serum response element of the c-fos promoter to influence hormone-induced promoter activation in Sertoli cells. Mol Endocrinol 13: 774-786.
7. Ehrlich LA, Chung HY, Ghobrial I, Choi SJ, Morandi F, Colla S, Rizzoli V, Roodman GD, Giuliani N. 2005. IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma. Blood 106: 1407-1414.
8. Janatpour MJ, McMaster MT, Genbacev O, Zhou Y, Dong J, Cross JC, Isrrael MA, Fisher SJ. 2000. Id-2 regulates critical aspects of human cytotrophoblast differentiation, invasion and migration. Development 127: 549-558.
9. Ji M, Li H, Suh HC, Klarmann KD, Yokota Y, Keller JR. 2008. Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins. Blood 112: 1068-1077.
10. Joo A, Aburatani H, Morii E, Iba H, Yoshimura A. 2004. STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-Fos expression. Oncogene 23: 726-734.
11. Khapli SM, Mangashetti LS, Yogesha SD, Wani MR. 2003. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-κB ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage. J Immunol 171: 142-151.
12. Kim K, Kim JH, Lee J, Jin HM, Kook H, Kim KK, Lee SY, Kim N. 2007. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109: 3253-3259.
13. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T. 2000. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191: 275-286.
14. Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, Taniguchi T, Takayanagi H, Takai T. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428: 758-763.
15. Lee JW, Chung HY, Ehrlich LA, Jelinek DF, Callander NS, Roodman GD, Choi SJ. 2004. IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells. Blood 103: 2308-2315.
16. Lee J, Kim K, Kim JH, Jin HM, Choi HK, Lee SH, Kook H, Kim KK, Yokota Y, Lee SY, Choi Y, Kim N. 2006. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood 107: 2686-2693.
17. Lee MS, Kim HS, Yeon JT, Choi SW, Chun CH, Kwak HB, Oh J. 2009. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway. J Immunol 183: 3390-3399.
18. Leeanansaksiri W, Wang H, Gooya JM, Renn K, Abshari M, Tsai S, Keller JR. 2005. IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development. J Immunol 174: 7014-7021.
19. Luan Y, Yu XP, Yang N, Frenkel S, Chen L, Liu CJ. 2008. p204 protein overcomes the inhibition of core binding factor α-1-mediated osteogenic differentiation by Id helix-loop-helix proteins. Mol Biol Cell 19: 2113-2126.
20. Luchin A, Suchting S, Merson T, Rosol TJ, Hume DA, Cassady AI, Ostrowski MC. 2001. Genetic and physical interactions between microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J Biol Chem 276: 36703-36710.
21. Massari ME, Murre C. 2000. Helix-loop-helix proteins: Regulators of transcription in eukaryotic organisms. Mol Cell Biol 20: 429-440.
22. Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF. 2000. Fosl1 is a transcription target of c-Fos during osteoclast differentiation. Nat Genet 24: 184-187.
23. Mocsai A, Humphrey MB, Van Ziffle JA, Burghardt T, Spusta SC, Majumdar S, Lanier LL, Lowell CA, Nakamura MC. 2004. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci USA 101: 6158-6163.
24. Norton JD. 2000. ID helix-loop-helix in cell growth, differentiation and tumorigenesis. J Cell Sci 113: 3897-3905.
25. Otero JE, Dai S, Alhawagri MA, Darwech I, Abu-Amer Y. 2010. IKKβ activation is sufficient for RANK-independent osteoclast differentiation and osteolysis. J Bone Miner Res 25: 1282-1294.
26. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science 289: 1508-1514.
27. Roodman GD. 2002. Role of the bone marrow microenvironment in multiple myeloma. J Bone Miner Res 17: 1921-1925.
28. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345-357.
29. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T. 2000. T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 408: 600-605.
30. Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T. 2002a. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416: 744-749.
31. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. 2002b. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3: 889-901.
32. 2 production and decreasing OPG production by osteoblasts. Life Sci 77: 615-626.
33. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
34. Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, Xing L, Boyce BF. 2007. NF-κB p50 and p52 regulate receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem 282: 18245-18253.